Introduction
stroke, post-stroke spasticity, spasticity, pain
STROKE
The cost of managing stroke places a significant burden on the individual, families
and the economy.Botulinum toxin is one treatment that can reduce spasticityWe have previously demonstrated that screening and treating spasticity early, on
first presentation after the first stroke in patients who have no useful arm
function, with botulinum toxin prevents contractures, reduces pain, and does not
interfere with functional recovery (EUBoSS Trial).Using data from the previous trial we aim to Identify the major cost drivers in the management of patients with
post-stroke spasticity and contractures.Conduct a cost-consequences analysis of botulinum toxin in the management
of patients with post-stroke spasticity and
contractures.